重症肺炎的快速精准诊断:重症社区获得性肺炎与医院获得性肺炎/呼吸机相关性肺炎的异同
本文聚焦重症社区获得性肺炎(SCAP)与医院获得性肺炎/呼吸机相关性肺炎(HAP/VAP)在流行病学、病原学特征及诊断策略上的异同。中国SCAP前六位病原体依次为流感病毒、肺炎链球菌、肠杆菌科、嗜肺军团菌、肺炎支原体、鹦鹉热衣原体;HAP/VAP以细菌为主,革兰阴性杆菌占多数且耐药率更高。SCAP有成熟的重症分层系统,HAP/VAP缺乏标准化重症诊断标准。
要点
- SCAP与HAP/VAP主要病原谱不同,经验性治疗策略应区分。
- HAP/VAP病原菌耐药率显著高于CAP,需不同治疗路径。
- SCAP缺乏可培养病原,PCR与NGS等分子检测对快速诊断至关重要。
核心结论
- 临床医生应针对SCAP与HAP/VAP采取不同的快速精准诊断策略,在启动恰当经验性治疗的同时积极通过高级检测明确病原体。
研究设计与样本
- 本文为综述,围绕SCAP与HAP/VAP在流行病学、易感人群、病原学特征及疾病诊断等维度展开探讨。
主要发现
- 中国SCAP最常见六种病原体依次为流感病毒、肺炎链球菌、肠杆菌科、嗜肺军团菌、肺炎支原体、鹦鹉热衣原体。
- 中国HAP/VAP以细菌为主,革兰阴性杆菌占分离株的大多数。
- HAP/VAP病原体耐药率显著高于CAP对应病原体。
- SCAP已有成熟的重症分层系统,而HAP/VAP目前缺乏标准化的重症诊断标准。
- SCAP多数病原体难以培养,PCR与NGS等快速敏感分子检测方法对病原鉴定至关重要。
关键数值与推荐
- SCAP前六位病原体按频率降序为流感病毒、肺炎链球菌、肠杆菌科、嗜肺军团菌、肺炎支原体、鹦鹉热衣原体。
- HAP/VAP诊断中培养联合抗菌药物敏感性试验(AST)起关键作用,合格的下呼吸道标本是准确鉴定的前提。
- HAP/VAP缺乏标准化重症诊断标准,可能导致评估临床严重程度时评分者间信度与诊断准确性低于CAP。
临床怎么用
- 对SCAP应优先采用PCR、NGS等分子检测快速鉴定难以培养的病原体。
- 对HAP/VAP应重视合格下呼吸道标本的培养联合AST以指导精准治疗。
- 启动经验性治疗的同时应积极通过高级诊断手段明确病原体,以实现精准医学目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe pneumonia, as a critical and prevalent condition of the respiratory system, poses a significant threat to patient survival and health outcomes. This article focuses on the similarities and differences between community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). There is significant divergence in the predominant pathogens between severe community-acquired pneumonia (SCAP) and HAP/VAP. Epidemiologic data from China has identified the six most prevalent SCAP pathogens as influenza virus, Streptococcus pneumoniae, Enterobacteriaceae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydia psittaci (listed in descending order of frequency). In contrast, HAP/VAP cases in China are predominantly bacterial, with Gram-negative bacilli accounting for the majority of isolates. The antimicrobial resistance profiles of SCAP and HAP/VAP pathogens are markedly distinct: HAP/VAP pathogens exhibit substantially higher resistance rates than their CAP counterparts, necessitating different therapeutic approaches. In terms of severity assessment criteria, SCAP has well-established severity stratification systems, whereas HAP/VAP currently lacks standardized diagnostic criteria for severe cases. This discrepancy may lead to reduced inter-rater reliability and diagnostic accuracy when evaluating clinical severity compared to CAP. For etiological diagnosis, SCAP and HAP/VAP require distinct diagnostic approaches. Culture combined with antimicrobial susceptibility testing (AST) plays a pivotal role in HAP/VAP diagnosis. Proper lower respiratory tract specimens are a prerequisite for accurate identification. In contrast, most SCAP pathogens are difficult to culture; therefore, rapid and sensitive molecular detection methods, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), are essential for SCAP pathogen identification. Clinicians should develop a rapid and precise diagnostic approach for pneumonia management, applying distinct strategies for SCAP versus HAP/VAP. While initiating appropriate empirical therapy, active identification of causative pathogens through advanced diagnostics should be pursued in order to achieve the goals of precision medicine and ultimately improve patient outcomes. 重症肺炎作为呼吸系统常见危重症,严重威胁患者生命健康。本文聚焦于重症肺炎中社区获得性肺炎与医院获得性肺炎/呼吸机相关性肺炎在临床精准诊疗方面的异同点,从流行病学、易感人群、病原学特征、疾病诊断等重要维度展开探讨,旨在为重症肺炎的快诊快治和精准诊治提供参考。.
引用
- Su, He. [Rapid and accurate diagnosis of severe pneumonia: similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40925731. doi:10.3760/cma.j.cn112147-20250618-00340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。